Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
New heart ablation tech shows promise for AFib patients
Disease control CompletedThis study tested a special mapping system and catheters to treat a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). 415 people who had never had this procedure before took part. The goal was to see if the system could safely and effectively stop AFib epi…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:17 UTC
-
New sphincter device cuts leakage in men after prostate surgery
Disease control CompletedThis study tested the AMS 800 Artificial Urinary Sphincter in 145 men who had stress urinary incontinence after prostate surgery. The main goal was to see if the device reduced urine leakage by at least 50% after 12 months. The approach involved surgically implanting the device t…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:16 UTC
-
Heart rhythm study tracks AF progression years after ablation
Disease control CompletedThis study followed 364 people with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) who had already received ablation treatment in an earlier trial. Researchers compared two ablation methods—pulsed field ablation and thermal ablation—to see how …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:15 UTC
-
Could a tiny heart implant replace daily blood thinners for AF patients?
Disease control CompletedThis study tested whether closing off a small part of the heart (the left atrial appendage) with the WATCHMAN FLX device is a safe and effective alternative to taking daily blood thinners after a common heart procedure for atrial fibrillation. It involved 1600 high-risk patients.…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New freezing technique shows promise for heart rhythm disorder
Disease control CompletedThis study tested a device that freezes small areas of heart tissue to stop irregular heartbeats (atrial fibrillation). 295 patients were treated and followed for a year to see if the procedure was safe and prevented heart rhythm problems. The goal is to control the condition, no…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Heart implant healing tracked with high-tech scans in 43 patients
Disease control CompletedThis study looked at how tissue grows over the WATCHMAN FLX Pro device after it is placed in the heart to prevent strokes in people with atrial fibrillation. Researchers used CT scans and echocardiograms to check for thickening on the device surface at 14 days, 45 days, and 3 mon…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Gel shield spares rectum during prostate radiation
Disease control CompletedThis study tested a gel called SpaceOAR that is injected between the prostate and rectum before radiation therapy for early-stage prostate cancer. The gel creates a temporary space to protect the rectum from radiation damage. The study involved 15 men in China and measured how we…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New embolic device shows promise in stopping tumor bleeding
Disease control CompletedThis study looked at how well and how safely the Obsidio device blocks blood vessels to control bleeding from hypervascular tumors. It involved 125 patients in the U.S. who were treated with Obsidio. The main goals were to see if the device successfully blocked the target vessels…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New device offers hope for AFib patients seeking stroke protection without lifelong meds
Disease control CompletedThis study tested the WATCHMAN FLX Pro device in 949 people with non-valvular atrial fibrillation who are at risk for stroke and bleeding. The device is implanted to close off a part of the heart where clots often form, aiming to reduce stroke risk without needing lifelong blood …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New balloon treatment shows promise for leg artery blockages
Disease control CompletedThis study tested a special balloon coated with a drug (paclitaxel) to open blocked arteries in the leg. 123 people with leg pain due to poor blood flow were treated. The goal was to see if the balloon is safe and keeps arteries open longer, reducing the need for repeat procedure…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for stroke prevention: device offers alternative to blood thinners for AFib patients
Disease control CompletedThis study tested the WATCHMAN device, a small implant that closes off a part of the heart called the left atrial appendage, to prevent stroke in 481 people with atrial fibrillation who cannot take blood thinners. The goal was to see if the device is safe and effective at reducin…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New heart mapping tech aims to improve AFib ablation
Disease control CompletedThis study tested a new mapping feature (FARAVIEW) used with a special catheter (FARAWAVE NAV) to treat atrial fibrillation, a common heart rhythm problem. 50 adults with symptomatic AFib participated. The goal was to see how well the technology helped doctors isolate and treat t…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New heart zapping technique shows promise for persistent AFib
Disease control CompletedThis study tested a new device called FARAPULSE that uses electrical pulses to treat a type of irregular heartbeat called persistent atrial fibrillation. 669 people with symptoms that didn't improve with medication took part. The goal was to see if the procedure is safe and works…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New stent study shows promise for leg artery disease patients
Disease control CompletedThis study looked at how well the ELUVIA drug-coated stent works in real-world patients with blocked arteries in the leg. About 291 adults received the stent and were followed for two years. Researchers measured changes in quality of life and walking ability to see if the stent h…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Balloon bypass opens blocked stomachs without surgery
Symptom relief CompletedThis study tested a new procedure using an endoscope and balloons to create a bypass around a stomach blockage caused by cancer. 51 patients with advanced cancer who could not eat or drink normally took part. The goal was to see if the procedure could safely allow them to eat aga…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 17, 2026 02:15 UTC
-
Laser showdown: breaking vs. dusting kidney stones
Symptom relief CompletedThis study looked at two ways to use a laser during surgery to remove kidney stones. Twenty adults with kidney stones had a procedure called flexible ureteroscopy. They were randomly assigned to have the laser either break the stone into pieces or turn it into dust. The goal was …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New brain stimulation tweak shows promise for Parkinson's patients
Symptom relief CompletedThis study tested a new way to program deep brain stimulation (DBS) devices in 15 people with Parkinson's disease. The goal was to see if this different programming approach could improve their quality of life. Participants already had DBS implants and were monitored for changes …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
New laser zaps away prostate troubles in minutes
Symptom relief CompletedThis study tested a special laser fiber to treat an enlarged prostate in 20 men who were already scheduled for surgery. The goal was to see how quickly and safely the laser could remove extra prostate tissue. Participants were followed for 3 months after the procedure to check fo…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
New study tracks pain relief from radiofrequency ablation
Symptom relief CompletedThis study looked at how well radiofrequency (RF) ablation works for people with chronic pain. Researchers followed 298 patients who were already scheduled to receive this treatment as part of their normal care. The main goal was to see how much patients felt their pain had impro…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated May 04, 2026 16:24 UTC
-
Heart device data collected from 500 chinese patients
Knowledge-focused CompletedThis study gathered real-world information on how well a special balloon catheter (Agent DCB) works for opening blocked heart arteries in Chinese patients. Researchers followed 500 adults for 12 months after their procedure to track heart-related events like heart attacks or the …
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Heart stent safety checked in 2,000+ patients
Knowledge-focused CompletedThis study looked at how well a specific heart stent (PROMUS PREMIER) works in everyday medical practice in China. Over 2,000 people with blocked heart arteries took part. Researchers tracked major heart problems like heart attacks or the need for repeat procedures for one year a…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Chronic pain patients share real results in new study
Knowledge-focused CompletedThis study gathered real-world information from 73 adults with chronic pain who were using or planning to use an approved medical device for pain relief. Researchers tracked changes in pain levels and other patient-reported outcomes to understand how these treatments work in ever…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Stent registry confirms safety and drainage success for kidney patients
Knowledge-focused CompletedThis study collected information from 379 people who received a Boston Scientific ureteral stent to treat a blocked ureter. Researchers tracked how often the stent successfully drained urine without needing another procedure, and recorded any serious side effects. The goal was to…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC